Oldest pages

From NeuroRehab.wiki

Showing below up to 50 results in range #901 to #950.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. COPD-PROGNOSIS‏‎ (20:03, 13 March 2023)
  2. SUDDEN ONSET DYSPNOEA DIFFERENTIALS‏‎ (20:03, 13 March 2023)
  3. PULMONARY FUNCTION TEST-EXAMPLES‏‎ (20:03, 13 March 2023)
  4. PULMONARY SARCOIDOSIS-DIFFERENTIALS‏‎ (20:03, 13 March 2023)
  5. MECHANICAL VENTILATION-ARDS MANAGEMENT‏‎ (20:03, 13 March 2023)
  6. PULMONARY EMBOLISM-COMPLICATIONS‏‎ (20:03, 13 March 2023)
  7. PULMONARY HTN-GROUP 2 & 3 TX‏‎ (20:03, 13 March 2023)
  8. COPD-CHRONIC RESPIRATORY SUPPORT‏‎ (20:03, 13 March 2023)
  9. PLEURAL EFFUSIONS-EXUDATE, INX‏‎ (20:03, 13 March 2023)
  10. OSA-SYMPTOMS‏‎ (20:03, 13 March 2023)
  11. PULMONARY EMBOLISM-PERC RULE‏‎ (20:03, 13 March 2023)
  12. PULMONARY PHYSIOLOGY-HYPOXEMIA CAUSES‏‎ (20:03, 13 March 2023)
  13. COPD-PULMONARY HTN & RHF‏‎ (20:03, 13 March 2023)
  14. PULMONARY FUNCTION TEST-FLOW VOLUME LOOPS‏‎ (20:03, 13 March 2023)
  15. PULMONARY SARCOIDOSIS-INVESTIGATION‏‎ (20:03, 13 March 2023)
  16. MECHANICAL VENTILATION-BASICS‏‎ (20:03, 13 March 2023)
  17. PULMONARY EMBOLISM-CTPA & VQ SCAN‏‎ (20:03, 13 March 2023)
  18. PULMONARY HTN-RIGHT HEART CATHETER‏‎ (20:03, 13 March 2023)
  19. COPD-DIAGNOSIS‏‎ (20:03, 13 March 2023)
  20. PLEURAL EFFUSIONS-FINDINGS‏‎ (20:03, 13 March 2023)
  21. PULMONARY EMBOLISM-RISK FACTORS‏‎ (20:03, 13 March 2023)
  22. PULMONARY PHYSIOLOGY-IMPAIRED OXYGEN DIFFUSION‏‎ (20:03, 13 March 2023)
  23. COPD-RISK FACTORS‏‎ (20:03, 13 March 2023)
  24. PULMONARY FUNCTION TEST-PATHOLOGY‏‎ (20:03, 13 March 2023)
  25. PULMONARY SARCOIDOSIS-MANAGEMENT‏‎ (20:03, 13 March 2023)
  26. MECHANICAL VENTILATION-INDICATIONS‏‎ (20:03, 13 March 2023)
  27. SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)-BLOOD‏‎ (20:03, 13 March 2023)
  28. ADHESIVE CAPSULITIS‏‎ (20:03, 13 March 2023)
  29. MORTON'S NEUROMA‏‎ (20:03, 13 March 2023)
  30. SYSTEMIC SCLEROSIS-DIFFUSE & LIMITED‏‎ (20:03, 13 March 2023)
  31. GOUT-ACUTE MANAGEMENT‏‎ (20:03, 13 March 2023)
  32. RHEUMATOID ARTHRITIS-LOWER LIMBS‏‎ (20:03, 13 March 2023)
  33. ARTHRITIS-PATTERNS OF PRESENTATION‏‎ (20:03, 13 March 2023)
  34. ANKLE SPRAIN-INX & MANAGEMENT‏‎ (20:03, 13 March 2023)
  35. ANTIPHOSPHOLIPID SYNDROME-INVESTIGATIONS‏‎ (20:03, 13 March 2023)
  36. RHEUMATOID ARTHRITIS-POOR PROGNOSIS (INVESTIGATIONS)‏‎ (20:03, 13 March 2023)
  37. SERONEGATIVE ARTHRITIS-PSORIATIC SUBTYPES‏‎ (20:03, 13 March 2023)
  38. SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)-CNS‏‎ (20:03, 13 March 2023)
  39. SYSTEMIC SCLEROSIS-GI‏‎ (20:03, 13 March 2023)
  40. REACTIVE ARTHRITIS-MANAGEMENT‏‎ (20:03, 13 March 2023)
  41. TRAUMA-MYOSITIS OSSIFICANS‏‎ (20:03, 13 March 2023)
  42. RHEUMATOID ARTHRITIS-MANAGEMENT (BIOLOGIC DMARDs)‏‎ (20:03, 13 March 2023)
  43. ARTHRITIS-PIPJ AND DIPJ NODULES‏‎ (20:03, 13 March 2023)
  44. ANKYLOSING SPONDYLITIS‏‎ (20:03, 13 March 2023)
  45. ANTIPHOSPHOLIPID SYNDROME-MANAGEMENT‏‎ (20:03, 13 March 2023)
  46. RHEUMATOID ARTHRITIS-RADIOLOGY‏‎ (20:03, 13 March 2023)
  47. SERONEGATIVE ARTHRITIS-SPONDYLOARTHRITIS‏‎ (20:03, 13 March 2023)
  48. SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)-CRITERIA‏‎ (20:03, 13 March 2023)
  49. DRUG-INDUCED MYOPATHY‏‎ (20:03, 13 March 2023)
  50. POLYARTERITIS NODOSA (PAN)‏‎ (20:03, 13 March 2023)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)